# Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct06704672` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06704672](<https://clinicaltrials.gov/study/NCT06704672>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06704672

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.

## Technical summary

Registry record NCT06704672. Randomized; no masking; primary purpose diagnostic. Start 2025-04-14 (actual); primary completion 2026-11-15 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 270 participants (planned count; ClinicalTrials.gov record NCT06704672, source copy `cardio:ctgov-nct06704672-2026-10-26`, retrieved 2026-10-31)
- Started: 2025-04-14 (actual) (ClinicalTrials.gov record NCT06704672, source copy `cardio:ctgov-nct06704672-2026-10-26`, retrieved 2026-10-31)
- Primary completion: 2026-11-15 (anticipated) (ClinicalTrials.gov record NCT06704672, source copy `cardio:ctgov-nct06704672-2026-10-26`, retrieved 2026-10-31)
- Completion: 2027-05-30 (anticipated) (ClinicalTrials.gov record NCT06704672, source copy `cardio:ctgov-nct06704672-2026-10-26`, retrieved 2026-10-31)
- Countries: Poland; Türkiye (ClinicalTrials.gov record NCT06704672, source copy `cardio:ctgov-nct06704672-2026-10-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06704672-2026-10-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus
- Condition: Type 1 Diabetes Mellitus
- Condition: Type 2 Diabetes Mellitus
- Intervention (Device): Accu-Chek SmartGuide CGM Solution
- Intervention (Device): Accu-Chek SmartGuide Sensor and Blinded Apps
- Intervention (Device): SMBG Device
- Lead sponsor: Hoffmann-La Roche
- Lead sponsor class: INDUSTRY
- Collaborator: Roche Diabetes Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Hoffmann-La Roche (`cardio:org-hoffmann-la-roche`)
- Registry lists this organization as a collaborator: Roche Diabetes Care (`cardio:org-roche-diabetes-care`)

## Provenance

Content hash: d8b538c71db36ff5510aab74d9feb6bf9b57eaf3ba6680a6dfea41d56c44ca1f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
